| 000 | 01734 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517032402.0 | ||
| 264 | 0 | _c20160517 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1873-5576 | ||
| 024 | 7 |
_a10.2174/1568009615666150506093155 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aD'yakonov, Vladimir A | |
| 245 | 0 | 0 |
_a11-Phenylundeca-5Z,9Z-dienoic Acid: Stereoselective Synthesis and Dual Topoisomerase I/IIα Inhibition. _h[electronic resource] |
| 260 |
_bCurrent cancer drug targets _c2015 |
||
| 300 |
_a504-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntigens, Neoplasm _xchemistry |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aCatalytic Domain |
| 650 | 0 | 4 |
_aDNA Topoisomerases, Type I _xchemistry |
| 650 | 0 | 4 |
_aDNA Topoisomerases, Type II _xchemistry |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aFatty Acids, Unsaturated _xchemical synthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Docking Simulation |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aProtein Conformation |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTopoisomerase I Inhibitors _xchemical synthesis |
| 650 | 0 | 4 |
_aTopoisomerase II Inhibitors _xchemical synthesis |
| 700 | 1 | _aDzhemileva, Lilya U | |
| 700 | 1 | _aMakarov, Aleksey A | |
| 700 | 1 | _aMulyukova, Alfiya R | |
| 700 | 1 | _aBaevd, Dmitry S | |
| 700 | 1 | _aKhusnutdinova, Elza K | |
| 700 | 1 | _aTolstikova, Tatiana G | |
| 700 | 1 | _aDzhemilev, Usein M | |
| 773 | 0 |
_tCurrent cancer drug targets _gvol. 15 _gno. 6 _gp. 504-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1568009615666150506093155 _zAvailable from publisher's website |
| 999 |
_c24895574 _d24895574 |
||